Asthma In-Home Monitoring (AIM) Trial

Study summary

OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits.

Ask AI to explain this study

Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiedIn-home telemonitoring of pediatric patients with persistent asthma

The study team can explain what participation involves.

Who it may be forMild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 10, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Tripler Army Medical Center

Study sponsor

Study overview

What this study is about

Purpose: Other
Study type: Interventional
Phase: Not applicable
Sponsor: Tripler Army Medical Center
Interventions being studied: Procedure: In-home telemonitoring of pediatric patients with persistent asthma

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Diagnosis of persistent asthma as defined using the NHLBI Expert Panel Report -2 guidelines Assignment of severity classification will be made at the beginning of the study based on severity of disease off therapy.
Dependent of active duty or retired US military personnel
6 to 17 years of age
Not moving from Oahu for 12 months after entry into study
Ability to receive cable modem hook-up in home
Willingness to learn to record and send MDI + spacer technique and peak flow two times week
Willing to attend asthma education follow-up visits either in person or electronically at 2- weeks, 6- weeks, 3-months and 6-month intervals after initiation into the study.
Willing to complete survey at the end of study period.
Willing to sign informed, written consent

Reasons someone may not be able to joinExclusion criteria

Diagnosis of mild intermittent asthma as defined by Expert Panel Report -2 guidelines.
\<6 and \>17 years of age
Family leaving Oahu within 12 months
Inability to receive cable modem hook-up in home
Unwilling or unable to learn to record and send MDI + spacer technique and peak flow and/or to attend asthma education follow-up visits either in person or electronically at initiation into study and at 2- weeks, 6- weeks, 3-months and 6 month intervals.
Unwilling to complete survey at the end of study period.
Patients or parents who decline to participate.
Patients with other chronic pulmonary disease (cystic fibrosis, bronchopulmonary dysplasia)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Tripler Army Medical CenterTripler AMC, Hawaii

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 10, 2025. Always confirm current availability with the study team.

View original record ↗